APA (7th ed.) Citation

Pflanz, S., Fosdick, A., Cihlar, T., & Subramanian, M. (2013). 394 IN VIVO ORAL DOSING OF THE TLR7 AGONIST GS-9620 INDUCES AN ANTI-VIRAL GENE EXPRESSION SIGNATURE IN MURINE LIVER CONCURRENT WITH UNDETECTABLE SERUM LEVELS OF IFN-a. Journal of Hepatology, 58, S162. https://doi.org/10.1016/S0168-8278(13)60396-7

Chicago Style (17th ed.) Citation

Pflanz, S., A. Fosdick, T. Cihlar, and M. Subramanian. "394 IN VIVO ORAL DOSING OF THE TLR7 AGONIST GS-9620 INDUCES AN ANTI-VIRAL GENE EXPRESSION SIGNATURE IN MURINE LIVER CONCURRENT WITH UNDETECTABLE SERUM LEVELS OF IFN-a." Journal of Hepatology 58 (2013): S162. https://doi.org/10.1016/S0168-8278(13)60396-7.

MLA (9th ed.) Citation

Pflanz, S., et al. "394 IN VIVO ORAL DOSING OF THE TLR7 AGONIST GS-9620 INDUCES AN ANTI-VIRAL GENE EXPRESSION SIGNATURE IN MURINE LIVER CONCURRENT WITH UNDETECTABLE SERUM LEVELS OF IFN-a." Journal of Hepatology, vol. 58, 2013, p. S162, https://doi.org/10.1016/S0168-8278(13)60396-7.